Anti-Mouse IFNβ – Purified
Anti-Mouse IFNβ – Purified
Product No.: I-440
- -
- -
Clone MIB-5E9.1 Target IFNβ Formats AvailableView All Product Type Monoclonal Antibody Alternate Names Interferon Beta Isotype IgG Applications N , WB |
Data
- -
- -
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Armenian Hamster Product Concentration 0.5 mg/ml Formulation This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. Storage and Handling This purified antibody is stable when stored at 2-8°C. Do not freeze. Country of Origin USA Shipping Next Day Ambient RRIDAB_2830689 Applications and Recommended Usage? Quality Tested by Leinco WB The purified antibody is recommended for Western blotting. The suggested concentration for this MIB-5E9.1 antibody for use in western blotting is 1-10 μg/ml. Additional Applications Reported In Literature ? N This antibody is recommended for neutralization of mouse IFN-β bioactivity Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Armenian Hamster Anti-Mouse IFNβ (Clone MIB-5E9.1) recognizes Mouse IFNβ. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Background Interferons (IFN) consist of two classes. The type I IFN class consists of 20 highly similar IFN-α proteins and a single IFN-ß protein. The second class, type II IFN, consists of a single protein, IFN-γ. IFN-α and IFN-ß signal through the same cell surface receptor IFNAR1 and have a similar range of biological activities including antiviral and antiproliferative activity. The type I IFNs also influence activation, growth and differentiation of T cells, B cells, macrophages, NK cells and other cell types such as endothelial cells and fibroblasts. IFN-ß has recently proven to be beneficial in patients with multiple sclerosis and could also be a potential therapy for rheumatoid arthritis. It is unclear what cellular mechanisms are involved in IFN-ß’s therapeutic effects, but they may be caused by a restoration of balance between pro- and anti-inflammatory cytokines. Research Area Apoptosis . Cell Biology . Cell Death . Signal Transduction . Tumor Suppressors References & CitationsTechnical ProtocolsCertificate of Analysis |
Formats Available
- -
- -
Prod No. | Description |
---|---|
I-440 | |
I-439 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.